相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erenumab versus topiramate for the prevention of migraine - a randomised, double-blind, active-controlled phase 4 trial
Uwe Reuter et al.
CEPHALALGIA (2022)
Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies
Koichi Hirata et al.
BRAIN AND BEHAVIOR (2022)
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Fenne Vandervorst et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Ariane K. Kawata et al.
HEADACHE (2021)
Comparative Effectiveness and Tolerability of the Pharmacology of Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide and Its Receptor for the Prevention of Chronic Migraine: a Network Meta-analysis of Randomized Controlled Trials
Chun-Pai Yang et al.
NEUROTHERAPEUTICS (2021)
Randomised, controlled trial of erenumab for the prevention of episodic migraine in patients from Asia, the Middle East, and Latin America: The EMPOwER study
Shuu-Jiun Wang et al.
CEPHALALGIA (2021)
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
Lucas Hendrik Overeem et al.
CNS DRUGS (2021)
Migraine remains second among the world's causes of disability, and first among young women: findings from GBD2019
T. J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Efficacy and safety of erenumab (AMG334) in episodic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Peter J. Goadsby et al.
CEPHALALGIA (2019)
Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache
T. J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2019)
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Kathleen B. Digre
HEADACHE (2019)
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
Messoud Ashina et al.
CEPHALALGIA (2018)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Early onset of efficacy with erenumab in patients with episodic and chronic migraine
Todd Schwedt et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Uwe Reuter et al.
LANCET (2018)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
A Primer on Effectiveness and Efficacy Trials
Amit G. Singal et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2014)
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Prophylactic treatment of migraine; the patient's view, a qualitative study
Frans Dekker et al.
BMC FAMILY PRACTICE (2012)
Prophylactic treatment of migraine by GPs: a qualitative study
Frans Dekker et al.
BRITISH JOURNAL OF GENERAL PRACTICE (2012)
Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life
Dawn C. Buse et al.
MAYO CLINIC PROCEEDINGS (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Adherence with Migraine Prophylaxis in Clinical Practice
Ariel Berger et al.
PAIN PRACTICE (2012)
Persistence with Migraine Prophylactic Treatment and Acute Migraine Medication Utilization in the Managed Care Setting
Avin Z. Yaldo et al.
CLINICAL THERAPEUTICS (2008)
In-office discussions of migraine: Results from the American migraine communication study
Richard B. Lipton et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
Topiramate in migraine prevention - Results of a large controlled trial
SD Silberstein et al.
ARCHIVES OF NEUROLOGY (2004)
Topiramate for migraine prevention - A randomized controlled trial
JL Brandes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Topiramate in migraine prophylaxis -: Results from a placebo-controlled trial with propranolol as an active control
HC Diener et al.
JOURNAL OF NEUROLOGY (2004)
Information about migraine disability influences physicians' perceptions of illness severity and treatment needs
WF Holmes et al.
HEADACHE (2001)
分享论文
